ロード中...
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by the presence of the Philadelphia chromosome and the bcr-abl gene. The discovery of tyrosine kinase inhibitors (TKIs) revolutionized therapy for CML, such that durable response, increased overall survival, and incr...
保存先:
| 出版年: | Biologics |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777272/ https://ncbi.nlm.nih.gov/pubmed/27013862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S67844 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|